Symproic (naldemedine) / Shionogi, Collegium Pharma 
Welcome,         Profile    Billing    Logout  

3 Trials

   Remove FilterRemove Filter

Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
Symproic (naldemedine) / Shionogi, Collegium Pharma
2021-000069-34: The effects of peripheral opioid receptor antagonism on recurrent acute pancreatitis Effekten af perifer opioid antagonisme på recidiverende akut pankreatitis

Ongoing
2/3
120
Europe
Naldemedine 0.2mg Film-coated Tablet, Film-coated tablet
Mech-Sense, Aalborg University Hospital, The Novo Nordisk Foundation, Shionogi B.V.
Recurrent acute pancreatitis, Recurrent acute inflammation of the pancreas, Diseases [C] - Digestive System Diseases [C06]
 
 
NCT05588323 / 2019-003577-25: Safety and Pharmacokinetics Study of Naldemedine in Paediatric Participants Receiving Opioids

Recruiting
1/2
24
Europe
Naldemedine, Rizmoic
Shionogi, Shionogi & Co. Ltd
Opioid-Induced Constipation (OIC)
08/24
08/24
NCT03720613: Risk of Major Adverse Cardiovascular Events for Naldemedine and Other Medications for Opioid Induced Constipation in Adults With Chronic Non-Cancer Pain

Recruiting
N/A
34532
US
Naldemedine, Symproic®, Lubiprostone, Amitiza®, Naloxegol, Movantik®
BioDelivery Sciences International, HealthCore, Inc.
Opioid-induced Constipation
11/30
11/30

Download Options